Pune, India -- (SBWIRE) -- 04/12/2019 -- The global In-Vitro Fertilization (IVF) Market is anticipated to grow at a constant CAGR around 9.8 % during the forecast period 2018 to 2026 and reach the market value around USD 38.7 billion by 2026.

According to the report named "In-Vitro Fertilization (IVF) Market - Global Industry Analysis, Growth, Share, Size, Trends and Forecast, 2018-2026". The market is driven by the growing incidence of infertility due to changes in lifestyle, government actions to better repayment policies and the on-going efforts of the contributors of industry. In the near future, the development of fertility procedures to treat male infertility such as ICSI should have a positive impact on growth. In addition, market drivers are expected to be provided with genomic tests that can prevent the transfer of genetic conditions during IVF. More and more insurance providers were encouraged to cover these procedures. More and more IVF treatments. This finally resulted in competitive pricing and reduced the cost of treatment driving the market with more treatment standardization and automation.

Free Download Sample Report Pages for Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1278

The behavioral change in society is the main contributing factor to the decreased TFR. This shift reflects the increased number of women employed by workers, advanced maternal age, a shift from rural to urban societies. The in vitro fertilization market during the prediction period is projected to drive such factors. Fatness is an additional factor that causes infertility to increase. The fat deposited on the abdomen preventively stimulates follicles by producing male hormones. In males, increased fat deposits reduce testosterone levels and lower sperm production.

In the next six years, regional growth is projected to be driven by the presence of a good compensation structure, such as US$ 50 million5-year U.S. Defense Department plans for freezing sperm / egg coverage. An increasing number of new clinics will also boost regional demand in order to provide better success rates for fertility. In Europe, the NHS covers 3 IVF cycles and covers freezing gametes. In addition, the region is attracting international customers, because the most egg donors are in countries such as Spain. The clinics also offer sex identification and other treatments with IVF,

Competitive Outlook

A standout amongst the most important transforms that have molded the worldwide medicinal outsourcing market, as it stands today, is the developing recognition among little and moderate sized healthcare firms that redistributing helps cut operational expenses and up effectiveness. This pattern, thusly, has been impelled by the way that few medicinal services associations do not have the venture capacities to set up undeniable IT branches of their own. It is essential to note here that the underlying expense of speculation for the normal charging the billing management software is impressively high. In addition, the re-appropriating of charging administrations is a demonstration of the trust that a healthcare organization puts in the merchant. Along these lines, the danger of merchants losing clients attributable to an information break or mistake in charging is high, which do not offered in NA.

View Detail Information with Complete TOC@ https://www.acumenresearchandconsulting.com/in-vitro-fertilization-ivf-market

End Use Insights

The segment of fertility clinics held the biggest market share in 2018 and is expected to lead over the forecast period. As demand for ART treatments rises, there is a considerable increase in the number of fertility clinics and ART centres. Licensed fertility clinics offer advice to pairs with design problems. On the basis of the seriousness of their issues, doctors and specialists plan IVF treatments for pairs. Clinics for fertility offer state-of - the-art equipment like micromanipulation, non-invasive RFID tags and more. In the forecast period, this factor is expected to further boost market growth.

Irvine Scientific, EMD Serono Inc., and OvaScience are Likely to Continue to Lead the Global IVF Market

The In-Vitro Fertilization (IVF) market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are; EMD Serono Inc.; OvaScience; Genea Biomedx; Vitrolife AB; Irvine Scientific; Thermo Fisher Scientific Inc.; Cook Medical Inc.; Cooper Surgical Inc.; Boston IVF, and Progyny, Inc.

Browse All official Market Research Reports Press Releases@ https://www.acumenresearchandconsulting.com/press-releases

TABLE OF CONTENT

CHAPTER 1. Industry Overview

1.1. Definition and Scope
1.1.1. Definition of In-Vitro Fertilization (IVF)
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. In-Vitro Fertilization (IVF) Market By Instrument
1.2.2.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Instrument (2015-2026)
1.2.2.2. Global In-Vitro Fertilization (IVF) Market Revenue Share By Instrument in 2017
1.2.2.3. Culture Media
1.2.2.4. Disposable Devices
1.2.2.5. Capital Equipment
1.2.2.6. Others
1.2.3. In-Vitro Fertilization (IVF) Market By Type
1.2.3.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By Type (2015-2026)
1.2.3.2. Frozen Non-donor
1.2.3.3. Fresh Non-donor
1.2.3.4. Frozen Donor
1.2.3.5. Fresh Donor
1.2.3.6. Others
1.2.4. In-Vitro Fertilization (IVF) Market By End Users
1.2.4.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison By End Users (2015-2026)
1.2.4.2. Fertility Clinics
1.2.4.3. Hospitals
1.2.4.4. Others
1.2.5. In-Vitro Fertilization (IVF) Market by Geography
1.2.5.1. Global In-Vitro Fertilization (IVF) Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.5.2. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.3. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.4. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.5. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)
1.2.5.6. Middle East and Africa (MEA) In-Vitro Fertilization (IVF) Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. Market Dynamics And Competition Analysis

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter's Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. Manufacturing Plants Analysis

3.1. Capacity and Commercial Production Date of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.3. R&D Status and Technology Source of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global In-Vitro Fertilization (IVF) Major Manufacturers in 2017

CHAPTER 4. In-Vitro Fertilization (IVF) Market By Instrument

4.1. Global In-Vitro Fertilization (IVF) Revenue By Instrument
4.2. Culture Media
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Disposable Devices
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Capital Equipment
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Other
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. In-Vitro Fertilization (IVF) Market By Type

5.1. Global In-Vitro Fertilization (IVF) Revenue By Type
5.2. Frozen Non-donor
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Fresh Non-donor
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Frozen Donor
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.5. Fresh Donor
5.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.6. Others
5.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. In-Vitro Fertilization (IVF) Market By End Users

6.1. Global In-Vitro Fertilization (IVF) Revenue By End Users
6.2. Fertility Clinics
6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Hospitals
6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Others
6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. North America In-Vitro Fertilization (IVF) Market By Country

7.1. North America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
7.3.1. U.S. In-Vitro Fertilization (IVF) Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.4. Canada
7.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
7.5. Mexico
7.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
7.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 8. Europe In-Vitro Fertilization (IVF) Market By Country

8.1. Europe In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
8.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.4. Germany
8.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.5. France
8.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.6. Spain
8.6.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
8.7. Rest of Europe
8.7.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
8.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 9. Asia-Pacific In-Vitro Fertilization (IVF) Market By Country

9.1. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
9.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.4. Japan
9.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.5. India
9.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.6. Australia
9.6.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.6.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.6.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.7. South Korea
9.7.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.7.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.7.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
9.8.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
9.8.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
9.8.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 10. Latin America In-Vitro Fertilization (IVF) Market By Country

10.1. Latin America In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
10.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.4. Argentina
10.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
10.5. Rest of Latin America
10.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
10.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 11. Middle East In-Vitro Fertilization (IVF) Market By Country

11.1. Middle East In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. Saudi Arabia
11.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.4. UAE
11.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
11.5. Rest of Middle East
11.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
11.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 12. Africa In-Vitro Fertilization (IVF) Market By Country

12.1. Africa In-Vitro Fertilization (IVF) Market Revenue and Growth Rate, 2015 - 2026 ($Million)
12.2. Africa In-Vitro Fertilization (IVF) Market Revenue Share Comparison, 2015 & 2026 (%)
12.3. South Africa
12.3.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.3.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.3.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.4. Egypt
12.4.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.4.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.4.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)
12.5. Rest of Africa
12.5.1. Market Revenue and Forecast By Instrument, 2015 - 2026 ($Million)
12.5.2. Market Revenue and Forecast By Type, 2015 - 2026 ($Million)
12.5.3. Market Revenue and Forecast By End Users, 2015 - 2026 ($Million)

CHAPTER 13. Company Profile

13.1. EMD Serono Inc.
13.1.1. Company Snapshot
13.1.2. Overview
13.1.3. Financial Overview
13.1.4. Type Portfolio
13.1.5. Key Developments
13.1.6. Strategies
13.2. OvaScience
13.2.1. Company Snapshot
13.2.2. Overview
13.2.3. Financial Overview
13.2.4. Type Portfolio
13.2.5. Key Developments
13.2.6. Strategies
13.3. Genea Biomedx
13.3.1. Company Snapshot
13.3.2. Overview
13.3.3. Financial Overview
13.3.4. Type Portfolio
13.3.5. Key Developments
13.3.6. Strategies
13.4. Vitrolife AB
13.4.1. Company Snapshot
13.4.2. Overview
13.4.3. Financial Overview
13.4.4. Type Portfolio
13.4.5. Key Developments
13.4.6. Strategies
13.5. Irvine Scientific
13.5.1. Company Snapshot
13.5.2. Overview
13.5.3. Financial Overview
13.5.4. Type Portfolio
13.5.5. Key Developments
13.5.6. Strategies
13.6. Thermo Fisher Scientific Inc.
13.6.1. Company Snapshot
13.6.2. Overview
13.6.3. Financial Overview
13.6.4. Type Portfolio
13.6.5. Key Developments
13.6.6. Strategies
13.7. Cook Medical Inc.
13.7.1. Company Snapshot
13.7.2. Overview
13.7.3. Financial Overview
13.7.4. Type Portfolio
13.7.5. Key Developments
13.7.6. Strategies
13.8. Cooper Surgical Inc.
13.8.1. Company Snapshot
13.8.2. Overview
13.8.3. Financial Overview
13.8.4. Type Portfolio
13.8.5. Key Developments
13.8.6. Strategies
13.9. Boston IVF
13.9.1. Company Snapshot
13.9.2. Overview
13.9.3. Financial Overview
13.9.4. Type Portfolio
13.9.5. Key Developments
13.9.6. Strategies
13.10. Progyny, Inc.
13.10.1. Company Snapshot
13.10.2. Overview
13.10.3. Financial Overview
13.10.4. Type Portfolio
13.10.5. Key Developments
13.10.6. Strategies
13.11. Others
13.11.1. Company Snapshot
13.11.2. Overview
13.11.3. Financial Overview
13.11.4. Type Portfolio
13.11.5. Key Developments
13.11.6. Strategies

CHAPTER 14. Research Approach

14.1. Research Methodology
14.1.1. Initial Data Search
14.1.2. Secondary Research
14.1.3. Primary Research
14.2. Assumptions and Scope

INQUIRY BEFORE BUYING@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/1278

The report is readily available and can be dispatched immediately after payment confirmation.

Buy this premium research report – https://www.acumenresearchandconsulting.com/buy-now/0/1278

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com | +1 407 915 4157

About Acumen Research and Consulting:
Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.